|
| Clinical Effect of Xuefu Zhuyu Capsule (XZC)on Pulmonary Heart Disease with Blood Stasis |
| Hits 1565 Download times 2254 Received:February 12, 2002 |
| View Full Text View/Add Comment Download reader |
| DOI
10.11656/j.issn.1672-1519.2002.06.10 |
| Key Words
Xuefu Zhuyu Capsule;pulmonary heart disease;blood stasis type;clinical observation |
| Author Name | Affiliation | | Zhao Xuequn | Tianjin First Central Hospital, Tianjin 300192, China | | Liu Jun | Tianjin First Central Hospital, Tianjin 300192, China | | Zheng Hong | Tianjin First Central Hospital, Tianjin 300192, China | | 禹玺 | Tianjin First Central Hospital, Tianjin 300192, China | | 陶家驹 | Tianjin First Central Hospital, Tianjin 300192, China |
|
| Abstract
|
| Objective: To observe the therapeutic effect of XZC on pulmonary heart disease with blood stasis. Method: 40 cases were divided into 2 groups: the treatment group (given XZC) and the control group (given bowel-soluble aspirin) with 28 to 30 days a course. Symptoms, signs and indexes of blood routine test and rheology were recorded before and after treatment. Result: The total effects were 95% and 70% in treatment group and control group respectively, and there was an obvious difference between them (P<0.05). The indexes of blood rheology, blood platelet, fibrinogen in both groups were improved, but difference between them were obvious (P<0.05). Conclusion: XZC provides an effective and safe method to treat pulmonary heart disease of blood stasis type with fewer side effects. |
|
|
|
|
|
|
|
